A22-NOI.pdf
PDF 104 KB Posted
- Solicitation number
- 75D301-26-Q-79025
About this file
This is a Notice of Intent to Award a Sole Source Contract from the Centers for Disease Control and Prevention (CDC), specifically the National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Division of Foodborne, Waterborne, and Environmental Diseases (DFWED), Enteric Diseases Laboratory Branch (EDLB). The CDC intends to award a Firm-Fixed-Price sole-source contract to Illumina, Inc., located at 5200 Illumina Way, San Diego, CA 92122, for a comprehensive maintenance and support agreement for an Illumina MiSeq i100 Plus Sequencer (Serial Number SH00687). The instrument is mission-critical to CDC's PulseNet foodborne disease surveillance network and performs whole-genome sequencing of enteric pathogens.
The procurement encompasses the Illumina MiSeq i100 Plus Silver Support Plan and includes preventative maintenance services, OEM-certified repair services, technical support and troubleshooting, software and firmware updates, replacement parts and labor with travel, reagent replacement for covered hardware failures, and Field Application Scientist support. The sole-source justification is based on FAR 13.106-1(b)(1), Only One Source Reasonably Available, as Illumina is the original equipment manufacturer and the only known source capable of providing OEM-certified maintenance, proprietary diagnostic software access, firmware updates, and manufacturer-authorized technical support. Interested organizations may submit capability statements by June 22, 2026 at 10:00 a.m. Eastern Time to Ashley Williams, Contract Specialist, at dal3@cdc.gov. The Government will evaluate responses solely to determine whether to conduct a competitive procurement, with the final determination remaining at the Government's discretion.
View the file
Other files
| File | Type | Posted |
|---|---|---|
| A13- SAP-Sole-Source-Justification RFO Part 8 and 12- CO signed 08Jun2026.pdf |
On GovTribe
Work with this file
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
NOTICE OF INTENT TO AWARD A SOLE SOURCE CONTRACT
The Centers for Disease Control and Prevention (CDC), National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Division of Foodborne, Waterborne, and Environmental Diseases (DFWED), Enteric Diseases Laboratory Branch (EDLB), intends to award a sole-source Firm-Fixed-Price contract to Illumina, Inc., 5200 Illumina Way, San Diego, CA 92122, for the procurement of an Illumina MiSeq i100 Plus Silver Support Plan maintenance agreement.
The purpose of this acquisition is to obtain a comprehensive OEM maintenance and support agreement for the Illumina MiSeq i100 Plus Sequencer S/N: SH00687. The instrument is a mission-critical component of CDC's PulseNet foodborne disease surveillance network and is used to perform whole-genome sequencing (WGS) of enteric pathogens. The maintenance agreement will provide preventative maintenance, technical support, software and firmware updates, replacement parts, repair services, and OEM-certified field service engineer support necessary to ensure continued reliable operation of the instrument.
Services to be acquired include:
• Illumina MiSeq i100 Plus Silver Support Plan
• Preventative maintenance services
• OEM-certified repair services
• Technical support and troubleshooting
• Software and firmware updates
• Replacement parts, labor, and travel
• Reagent replacement associated with covered hardware failures
• Field Application Scientist (FAS) support
This contract action is for services for which the Government intends to solicit and negotiate with only one source under the authority of FAR 13.106-1(b)(1), Only One Source Reasonably Available. Illumina, Inc. is the Original Equipment Manufacturer (OEM) of the MiSeq i100 Plus platform and is the only known source capable of providing OEM-certified maintenance, proprietary diagnostic software access, firmware updates, certified replacement parts, and manufacturer-authorized technical support necessary to maintain the instrument in accordance with factory specifications.
Interested organizations may identify their interest and capability to satisfy the Government's requirement by submitting a capability statement. This notice of intent is not a request for competitive quotations. However, all capability statements received by June 22, 2026 at 10:00 a.m. Eastern Time will be considered by the Government. A determination by the Government not to compete the proposed acquisition based upon responses to this notice is solely within the discretion of the Government.
Responses shall be submitted electronically to:
Ashley Williams Contract Specialist Email: dal3@cdc.gov
Responses must be received no later than June 22, 2026 at 10:00 a.m. Eastern Time.
Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement.
mailto:dal3@cdc.gov
File details come from the government source that posted it. Updated .